Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

Clinical trial NCT00133159 · COMPLETED

Trial details

NCT number: NCT00133159
Sponsor: Allergy Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type I Hypersensitivity

Start date: 2005-09-12
Primary completion: 2005-11-08
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.